Search Results - "Del Bello, Duilia"
-
1
Chemotherapy enhances vaccine‐induced antitumor immunity in melanoma patients
Published in International journal of cancer (01-01-2009)“…Combination of chemotherapy with cancer vaccines is currently regarded as a potentially valuable therapeutic approach for the treatment of some metastatic…”
Get full text
Journal Article -
2
Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A―Specific, Tumor-Reactive CTL in Melanoma Patients
Published in Cancer research (Chicago, Ill.) (15-09-2010)“…Combination of chemotherapy and immunotherapy to increase the effectiveness of an antitumor immune response is currently regarded as an attractive antitumor…”
Get full text
Journal Article -
3
Abstract 4406: Clinical efficacious combined chemo/immunotherapy differently activates AKT pathway and functionality of gp100 and Melan-A specific T cell clones
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract A phase II randomized clinical study is ongoing in our Institution to prove the clinical efficacy of dacarbazine (DTIC) one day before…”
Get full text
Journal Article -
4
Combination of DTIC and peptide-vaccination elicit a renewal of high-avidity late-differentiated T-cell clones in melanoma patients (156.6)
Published in The Journal of immunology (1950) (01-04-2011)“…Abstract Combination of chemo/immunotherapy to increase the effectiveness of the antitumor immune responses associated with a clinical efficacy is an…”
Get full text
Journal Article -
5
Human mena protein, a serex‐defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T‐cell immune response
Published in International journal of cancer (10-05-2004)“…Screening of a cDNA expression library from a primary breast tumor with the autologous patient serum led to the isolation of 6 cDNA clones corresponding to 3…”
Get full text
Journal Article -
6
Diversification of TCR repertoire in melanoma patients treated with chemotherapy before peptides-vaccination (41.19)
Published in The Journal of immunology (1950) (01-04-2009)“…Abstract Combining chemotherapy and immunotherapy is an attractive antitumor strategy. Recently we have reported that the administration of dacarbazine (DTIC)…”
Get full text
Journal Article -
7
Host immunosurveillance contributes to the control of erbB‐2 overexpression in HLA‐A2‐breast‐cancer patients
Published in International journal of cancer (22-12-1999)“…Overexpression of gp185erbB‐2 has been associated with reduced survival in breast‐cancer patients. Our earlier results, now confirmed in a larger cohort of…”
Get full text
Journal Article -
8
Polyclonal antibodies against gp185HER2 peptides : Their putative role in the identification of a particular HER2 status in patients with breast cancer
Published in Journal of immunotherapy (1997) (01-05-2001)“…The HER2 oncogene and its relative oncoprotein, gp185HER2, a transmembrane glycoprotein belonging to the epidermal growth factor receptor family, are…”
Get full text
Journal Article -
9
Low Frequency of ErbB-2 Proto-oncogene Overexpression in Human Leukocyte Antigen-A2-Positive Breast Cancer Patients
Published in JNCI : Journal of the National Cancer Institute (19-02-1997)“…Nistico et al describe a study examining the low frequency of ErbB-2 proto-oncogene overexpression in human leukocyte antigen-A2-positive breast cancer…”
Get full text
Journal Article